The MarketWatch News Department was not involved in the creation of this content.-- This marks the first live procedure at AAHS, as well as a first for Keenova. -- Treatment takes ...

Xiaflex was approved in 2010 for the treatment of Dupuytren’s contracture. Dupuytren’s contracture is a condition where nodules form under the skin in the palm of the hand. These nodules thicken and ...

Joel Embiid and the Sixers prioritized the present during the playoffs, pushing the five-time All-Star’s injury issues to the offseason as much as possible. With the Sixers now watching the remainder ...

Hand rehabilitation research has markedly benefited from the introduction of soft actuators in gloves. However, existing soft rehabilitation glove designs have several limitations in finger movements.

A groundbreaking surgical procedure combined with exciting new technological strides is offering new hope and help for amputees. Private Jackson Schroeder, an Army veteran, was one of the early few to ...

Dupuytren’s disease is a slowly progressive connective tissue disorder that can cause an affected finger to bend into the palm of the hand.1 It affects approximately 13% of the European population.(2) ...

We use our hands frequently everyday. Considering the manner we put them to use, it is not surprising that our hands are often prone to injuries. However, it is reassuring to know that most hand ...

Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the Company received a $7.5 million regulatory milestone from Pfizer, Inc. (Pfizer) following ...

NEW YORK & MALVERN, Pa.--(BUSINESS WIRE)-- XIAPEX® (collagenase clostridium histolyticum), a new non-surgical treatment option for Dupuytren’s contracture in adult patients with a palpable cord, has ...

BioSpecifics Technologies announced positive results from its Phase 3b MULTICORD study evaluating Xiaflex (collagenase clostridium histolyticum) for the concurrent treatment of adult Dupuytren’s ...

Swedish Orphan Biovitrum AB (publ) (Sobi) (SOBI.ST) today announced that the European Medicines Agency has approved Xiapex® (collagenase clostridium histolyticum, or CCH) for the treatment of two ...